Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 5 |
Descriptor
Adolescents | 5 |
Comparative Analysis | 5 |
Pain | 5 |
Symptoms (Individual… | 4 |
Depression (Psychology) | 3 |
Drug Therapy | 2 |
Outcomes of Treatment | 2 |
Severity (of Disability) | 2 |
Sleep | 2 |
Suicide | 2 |
Adolescent Development | 1 |
More ▼ |
Source
Journal of the American… | 2 |
Journal of Child Psychology… | 1 |
Journal of Clinical Child and… | 1 |
Research in Developmental… | 1 |
Author
Publication Type
Journal Articles | 5 |
Reports - Research | 5 |
Education Level
Secondary Education | 1 |
Audience
Location
Netherlands | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Empathic Responsiveness in Amygdala and Anterior Cingulate Cortex in Youths with Psychopathic Traits
Marsh, Abigail A.; Finger, Elizabeth C.; Fowler, Katherine A.; Adalio, Christopher J.; Jurkowitz, Ilana T. N.; Schechter, Julia C.; Pine, Daniel S.; Decety, Jean; Blair, R. J. R. – Journal of Child Psychology and Psychiatry, 2013
Background: Psychopathic traits are associated with increases in antisocial behaviors such as aggression and are characterized by reduced empathy for others' distress. This suggests that psychopathic traits may also impair empathic pain sensitivity. However, whether psychopathic traits affect responses to the pain of others versus the self…
Descriptors: Brain Hemisphere Functions, Psychopathology, Aggression, Antisocial Behavior
Murray, Caitlin B.; Murphy, Lexa K.; Palermo, Tonya M.; Clarke, Gregory M. – Journal of Clinical Child and Adolescent Psychology, 2012
The aims of this study were to (a) assess and compare sleep disturbances (including daytime and nighttime sleep patterns) in adolescents with depressive disorders and healthy peers, (b) examine the prevalence of pain in adolescents with depressive disorders and healthy peers, and (c) examine pubertal development, pain intensity, and depressive…
Descriptors: Adolescents, Puberty, Depression (Psychology), Sleep
Oeseburg, B.; Jansen, D. E. M. C.; Dijkstra, G. J.; Groothoff, J. W.; Reijneveld, S. A. – Research in Developmental Disabilities: A Multidisciplinary Journal, 2010
Valid community-based data on the prevalence of chronic diseases in adolescents (12-18 years) with intellectual disability (ID-adolescents) are scarce. The aim of this study was to assess the prevalence rates and the nature of chronic diseases in a population of ID-adolescents and to compare them with the rates among adolescents in the general…
Descriptors: Incidence, Mental Retardation, Adolescents, Foreign Countries
Wagner, Karen Dineen; Jonas, Jeffrey; Findling, Robert L.; Ventura, Daniel; Saikali, Khalil – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: Escitalopram is a selective serotonin reuptake inhibitor antidepressant indicated for use in adults. This trial examined the efficacy and safety of escitalopram in pediatric depression. Method: Patients (6-17 years old) with major depressive disorder were randomized to receive 8 weeks of double-blind flexibly dosed treatment with…
Descriptors: Pediatrics, Least Squares Statistics, Depression (Psychology), Drug Therapy
Emslie, Graham; Kratochvil, Christopher; Vitiello, Benedetto; Silva, Susan; Mayes, Taryn; McNulty, Steven; Weller, Elizabeth; Waslick, Bruce; Casat, Charles; Walkup, John; Pathak, Sanjeev; Rohde, Paul; Posner, Kelly; March, John – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO). Method: Safety assessments included adverse events (AEs) collected by spontaneous report, as well as systematic…
Descriptors: Safety, Patients, Adolescents, Suicide